Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive Milieu alterations

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 436-451

  Figel, Ainhoa M ^a   Brech, Dorothee ^a   Prinz, Petra U ^a   Lettenmeyer, Ulrike K ^a   Eckl, Judith ^a   Turqueti Neves, Adriana ^a   Mysliwietz, Josef ^a   Anz, David ^b   Rieth, Nicole ^b   Muenchmeier, Niklas ^b   Buchner, Alexander ^c,d   Porubsky, Stefan ^e   Siegert, Sabine I ^b   Segerer, Stephan ^f   Nelson, Peter J ^b   Noessner, Elfriede ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD209 ANTIGEN; CD3 ANTIGEN; CD3 ZETA ANTIGEN; CHEMOKINE; GELATINASE B; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER IMMUNOTHERAPY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; LYMPHOCYTE FUNCTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES; CROSS-PRIMING; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TUMOR CELLS, CULTURED;

EID: 80052471748     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.011     Document Type: Article

References (62)

1. N.J. Vogelzang, and W.M. Stadler Kidney cancer Lancet 352 1998 1691 1696
2. M.B. Atkins, M. Regan, and D. McDermott Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma Clin Cancer Res 10 2004 6342S 6346S
3. W.S. Webster, C.M. Lohse, R.H. Thompson, H. Dong, X. Frigola, D.L. Dicks, S. Sengupta, I. Frank, B.C. Leibovich, M.L. Blute, J.C. Cheville, and E.D. Kwon Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival Cancer 107 2006 46 53
4. J.S. Schleypen, N. Baur, R. Kammerer, P.J. Nelson, K. Rohrmann, E.F. Grone, M. Hohenfellner, A. Haferkamp, H. Pohla, D.J. Schendel, C.S. Falk, and E. Noessner Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma Clin Cancer Res 12 2006 718 725
5. B. Frankenberger, E. Noessner, and D.J. Schendel Immune suppression in renal cell carcinoma Semin Cancer Biol 17 2007 330 343
6. R.M. Steinman, and J. Banchereau Taking dendritic cells into medicine Nature 449 2007 419 426
7. A. Mantovani, P. Romero, A.K. Palucka, and F.M. Marincola Tumour immunity: effector response to tumour and role of the microenvironment Lancet 371 2008 771 783
8. C. Auffray, M.H. Sieweke, and F. Geissmann Blood monocytes: development, heterogeneity, and relationship with dendritic cells Annu Rev Immunol 27 2009 669 692
9. F. Geissmann, S. Gordon, D.A. Hume, A.M. Mowat, and G.J. Randolph Unravelling mononuclear phagocyte heterogeneity Nat Rev Immunol 10 2010 453 460
10. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964
11. S. Segerer, F. Heller, M.T. Lindenmeyer, H. Schmid, C.D. Cohen, D. Draganovici, J. Mandelbaum, P.J. Nelson, H.J. Grone, E.F. Grone, A.M. Figel, E. Nossner, and D. Schlondorff Compartment specific expression of dendritic cell markers in human glomerulonephritis Kidney Int 74 2008 37 46
12. S.H. Naik Demystifying the development of dendritic cell subtypes, a little Immunol Cell Biol 86 2008 439 452
13. W.R. Heath, and F.R. Carbone Dendritic cell subsets in primary and secondary T cell responses at body surfaces Nat Immunol 10 2009 1237 1244
14. R.M. Steinman, and J. Idoyaga Features of the dendritic cell lineage Immunol Rev 234 2010 5 17
15. X. Dong, S. Swaminathan, L.A. Bachman, A.J. Croatt, K.A. Nath, and M.D. Griffin Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury Kidney Int 71 2007 619 628
16. C. Kurts, F. Heymann, V. Lukacs-Kornek, P. Boor, and J. Floege Role of T cells and dendritic cells in glomerular immunopathology Semin Immunopathol 29 2007 317 335
17. J. Scholz, V. Lukacs-Kornek, D.R. Engel, S. Specht, E. Kiss, F. Eitner, J. Floege, H.J. Groene, and C. Kurts Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis J Am Soc Nephrol 19 2008 527 537
18. A.M. Woltman, J.W. de Fijter, K. Zuidwijk, A.G. Vlug, I.M. Bajema, S.W. van der Kooij, V. van Ham, and C. van Kooten Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions Kidney Int 71 2007 1001 1008
19. M. Kobayashi, K. Suzuki, M. Yashi, M. Yuzawa, N. Takayashiki, and T. Morita Tumor infiltrating dendritic cells predict treatment response to immmunotherapy in patients with metastatic renal cell carcinoma Anticancer Res 27 2007 1137 1141
20. M. Gigante, A. Blasi, A. Loverre, V. Mancini, M. Battaglia, F.P. Selvaggi, E. Maiorano, A. Napoli, G. Castellano, W.J. Storkus, L. Gesualdo, and E. Ranieri Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine Mol Immunol 46 2009 893 901
21. K. Ebelt, G. Babaryka, A.M. Figel, H. Pohla, A. Buchner, C.G. Stief, W. Eisenmenger, T. Kirchner, D.J. Schendel, and E. Noessner Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma Prostate 68 2008 1 10
22. M.J. Pittet, D.E. Speiser, D. Valmori, J.C. Cerottini, and P. Romero Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression J Immunol 164 2000 1148 1152
23. N. Halama, M. Braun, C. Kahlert, A. Spille, C. Quack, N. Rahbari, M. Koch, J. Weitz, M. Kloor, I. Zoernig, P. Schirmacher, K. Brand, N. Grabe, and C.S. Falk Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines Clin Cancer Res 17 2011 678 689
24. R. Gazit, and O. Mandelboim Natural killer cells at the tumors microenvironment E. Yefenof, Innate and adaptive immunity in the tumor microenvironment 2008 Springer New York 171 193
25. B. Engels, E. Noessner, B. Frankenberger, T. Blankenstein, D.J. Schendel, and W. Uckert Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes Hum Gene Ther 16 2005 799 810
26. R. Djafarzadeh, E. Noessner, H. Engelmann, D.J. Schendel, M. Notohamiprodjo, I. von Luettichau, and P.J. Nelson GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing Oncogene 25 2006 1496 1508
27. V. Milani, B. Frankenberger, O. Heinz, A. Brandl, S. Ruhland, R.D. Issels, and E. Noessner Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response Int Immunol 17 2005 257 268
28. J. Carlsson, and J.M. Yuhas Liquid-overlay culture of cellular spheroids Recent Results Cancer Res 95 1984 1 23
29. H. Bendz, S.C. Ruhland, M.J. Pandya, O. Hainzl, S. Riegelsberger, C. Brauchle, M.P. Mayer, J. Buchner, R.D. Issels, and E. Noessner Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling J Biol Chem 282 2007 31688 31702
30. C.D. Gerharz, U. Ramp, M. Dejosez, C. Mahotka, B. Czarnotta, U. Bretschneider, I. Lorenz, M. Muller, P.H. Krammer, and H.E. Gabbert Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control Lab Invest 79 1999 1521 1534
31. J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pages, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoue, P. Bruneval, P.H. Cugnenc, Z. Trajanoski, W.H. Fridman, and F. Pages Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960 1964
32. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, G. Regnani, A. Makrigiannakis, H. Gray, K. Schlienger, M.N. Liebman, S.C. Rubin, and G. Coukos Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 2003 203 213
33. V. Ficarra, A. Galfano, M. Mancini, G. Martignoni, and W. Artibani TNM staging system for renal-cell carcinoma: current status and future perspectives Lancet Oncol 8 2007 554 558
34. M. Relloso, A. Puig-Kroger, O.M. Pello, J.L. Rodriguez-Fernandez, G. de la Rosa, N. Longo, J. Navarro, M.A. Munoz-Fernandez, P. Sanchez-Mateos, and A.L. Corbi DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN. TGF-beta, and anti-inflammatory agents J Immunol 168 2002 2634 2643
35. E.J. Soilleux, L.S. Morris, G. Leslie, J. Chehimi, Q. Luo, E. Levroney, J. Trowsdale, L.J. Montaner, R.W. Doms, D. Weissman, N. Coleman, and B. Lee Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro J Leukoc Biol 71 2002 445 457
36. S.R. Krutzik, B. Tan, H. Li, M.T. Ochoa, P.T. Liu, S.E. Sharfstein, T.G. Graeber, P.A. Sieling, Y.J. Liu, T.H. Rea, B.R. Bloom, and R.L. Modlin TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells Nat Med 11 2005 653 660
37. D.M. Kuang, Q. Zhao, J. Xu, J.P. Yun, C. Wu, and L. Zheng Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways J Immunol 181 2008 3089 3098
38. S.A. Siddiqui, X. Frigola, S. Bonne-Annee, M. Mercader, S.M. Kuntz, A.E. Krambeck, S. Sengupta, H. Dong, J.C. Cheville, C.M. Lohse, C.J. Krco, W.S. Webster, B.C. Leibovich, M.L. Blute, K.L. Knutson, and E.D. Kwon Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma Clin Cancer Res 13 2007 2075 2081
39. L.M. Coussens, C.L. Tinkle, D. Hanahan, and Z. Werb MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 2000 481 490
40. C.E. Lewis, and J.W. Pollard Distinct role of macrophages in different tumor microenvironments Cancer Res 66 2006 605 612
41. M.J. Chuang, K.H. Sun, S.J. Tang, M.W. Deng, Y.H. Wu, J.S. Sung, T.L. Cha, and G.H. Sun Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells Cancer Sci 99 2008 905 913
42. T.H. Schreiber, V.V. Deyev, J.D. Rosenblatt, and E.R. Podack Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination Cancer Res 69 2009 2026 2033
43. S. Attig, J. Hennenlotter, G. Pawelec, G. Klein, S.D. Koch, H. Pircher, S. Feyerabend, D. Wernet, A. Stenzl, H.G. Rammensee, and C. Gouttefangeas Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas Cancer Res 69 2009 8412 8419
44. D.A. Hume, I.L. Ross, S.R. Himes, R.T. Sasmono, C.A. Wells, and T. Ravasi The mononuclear phagocyte system revisited J Leukoc Biol 72 2002 621 627
45. D. Ferenbach, and J. Hughes Macrophages and dendritic cells: what is the difference? Kidney Int 74 2008 5 7
46. U. Kammerer, A.O. Eggert, M. Kapp, A.D. McLellan, T.B. Geijtenbeek, J. Dietl, Y. van Kooyk, and E. Kampgen Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy Am J Pathol 162 2003 887 896
47. L. Tailleux, N. Pham-Thi, A. Bergeron-Lafaurie, J.L. Herrmann, P. Charles, O. Schwartz, P. Scheinmann, P.H. Lagrange, J. de Blic, A. Tazi, B. Gicquel, and O. Neyrolles DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis PLoS Med 2 2005 e381
48. B. Konig, F. Steinbach, B. Janocha, A. Drynda, M. Stumm, C. Philipp, E.P. Allhoff, and W. Konig The differential expression of proinflammatory cytokines IL-6. IL-8 and TNF-alpha in renal cell carcinoma Anticancer Res 19 1999 1519 1524
49. U. Bharadwaj, M. Li, R. Zhang, C. Chen, and Q. Yao Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation Cancer Res 67 2007 5479 5488
50. D. Duluc, Y. Delneste, F. Tan, M.P. Moles, L. Grimaud, J. Lenoir, L. Preisser, I. Anegon, L. Catala, N. Ifrah, P. Descamps, E. Gamelin, H. Gascan, M. Hebbar, and P. Jeannin Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells Blood 110 2007 4319 4330
51. Y. Huang, P. Johnston, B. Zhang, A. Zakari, T. Chowdhry, R.R. Smith, E. Marban, H. Rabb, and K.L. Womer Kidney-derived stromal cells modulate dendritic and T cell responses J Am Soc Nephrol 20 2009 831 841
52. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 2004 2731 2738
53. X. Dong, L.A. Bachman, M.N. Miller, K.A. Nath, and M.D. Griffin Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction Kidney Int 74 2008 1294 1309
54. X. Dong, S. Swaminathan, L.A. Bachman, A.J. Croatt, K.A. Nath, and M.D. Griffin Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney Kidney Int 68 2005 1096 1108
55. E. Klechevsky, R. Morita, M. Liu, Y. Cao, S. Coquery, L. Thompson-Snipes, F. Briere, D. Chaussabel, G. Zurawski, A.K. Palucka, Y. Reiter, J. Banchereau, and H. Ueno Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells Immunity 29 2008 497 510
56. A. Sica, and V. Bronte Altered macrophage differentiation and immune dysfunction in tumor development J Clin Invest 117 2007 1155 1166
57. A. Singh, and M. Suresh A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory J Leukoc Biol 82 2007 1201 1211
58. K.A. Shafer-Weaver, S.K. Watkins, M.J. Anderson, L.J. Draper, A. Malyguine, W.G. Alvord, N.M. Greenberg, and A.A. Hurwitz Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells Cancer Res 69 2009 6256 6264
59. C.N. Janicki, S.R. Jenkinson, N.A. Williams, and D.J. Morgan Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration Cancer Res 68 2008 2993 3000
60. S. Kim, H. Takahashi, W.W. Lin, P. Descargues, S. Grivennikov, Y. Kim, J.L. Luo, and M. Karin Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis Nature 457 2009 102 106
61. D.G. DeNardo, P. Andreu, and L.M. Coussens Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity Cancer Metastasis Rev 29 2010 309 316
62. F. Heymann, C. Meyer-Schwesinger, E.E. Hamilton-Williams, L. Hammerich, U. Panzer, S. Kaden, S.E. Quaggin, J. Floege, H.J. Grone, and C. Kurts Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury J Clin Invest 119 2009 1286 1297